Cargando…

COVID-19 and its implications on the clinico-radiological course of multiple sclerosis: A case–control study

Mostrar otras versiones (1)

BACKGROUND: Multiple sclerosis (MS) is an immune-mediated disease that has been related to several risk factors such as various viral infections. We carried out this study in order to establish a relationship between COVID-19 infection and MS severity. METHODS: In a case–control study, we recruited...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahmani, Mohammad, Moghadasi, Abdorreza Naser, Shahi, Shayan, Eskandarieh, Sharareh, Azizi, Hossein, Hasanzadeh, Alireza, Ahmadzade, Ali, Dehnavi, Ali Zare, Farahani, Ramin Hamidi, Aminianfar, Mohammad, Naeini, Alireza Ranjbar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983351/ https://www.ncbi.nlm.nih.gov/pubmed/36883067 http://dx.doi.org/10.1016/j.medcle.2022.06.021

Ejemplares similares

COVID-19 and its implications on the clinico-radiological course of multiple sclerosis: A case–control study
por: Rahmani, Mohammad, et al.
Publicado: (2023)

Economic sanctions against Iran as an important factor in threatening the health of patients with multiple sclerosis
por: Sahraian, Mohammad Ali, et al.
Publicado: (2021)

Implementing coronavirus disease 2019 scale-up registry protocol in national multiple sclerosis registry system of Iran
por: Eskandarieh, Sharareh, et al.
Publicado: (2021)

Depression, anxiety, and fear of COVID-19 in patients with multiple sclerosis in pandemic era: a cross-sectional study
por: Alirezaei, Mohammad, et al.
Publicado: (2021)

Effect of fluvoxamine on preventing neuropsychiatric symptoms of post COVID syndrome in mild to moderate patients, a randomized placebo-controlled double-blind clinical trial
por: Farahani, Ramin Hamidi, et al.
Publicado: (2023)

Association of cigarette smoking with neuromyelitis optica-immunoglobulin G sero-positivity in neuromyelitis optica spectrum disorder
por: Eskandarieh, Sharareh, et al.
Publicado: (2019)

Medical history risk factors in primary progressive multiple sclerosis: A case-control study
por: Maroufi, Hossein, et al.
Publicado: (2021)

Clinical, Laboratory and Imaging Characteristics of Hospitalized COVID-19 Patients with Neurologic Involvement; a Cross-Sectional Study
por: Zare Dehnavi, Ali, et al.
Publicado: (2022)

Can pulse steroid therapy increase the risk of infection by COVID-19 in patients with multiple sclerosis?
por: Naser Moghadasi, Abdorreza, et al.
Publicado: (2021)

Waterpipe and cigarette smoking and drug and alcohol consumption, and the risk of primary progressive multiple sclerosis: A population-based case-control study
por: Mortazavi, Seyyed Hosein, et al.
Publicado: (2023)

Association of body mass index and physical activity with fatigue, depression, and anxiety among Iranian patients with multiple sclerosis
por: Rezaeimanesh, Nasim, et al.
Publicado: (2023)

Effect of Rituximab on the cognitive impairment in patients with secondary progressive multiple sclerosis
por: Salehizadeh, Saeideh, et al.
Publicado: (2022)

Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis
por: Azadvari, Mohaddeseh, et al.
Publicado: (2020)

Neuromyelitis optica with linear enhancement of corpus callosum in brain magnetic resonance imaging with contrast: a case report
por: Sahraian, Mohammad Ali, et al.
Publicado: (2015)

The co-occurrence of multiple sclerosis and Evans syndrome: A case report
por: Salehizadeh, Saeideh, et al.
Publicado: (2020)

Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms
por: Rezaeimanesh, Nasim, et al.
Publicado: (2020)

Multiple sclerosis and human leukocyte antigen genotypes: Focus on the Middle East and North Africa region
por: Maghbooli, Zhila, et al.
Publicado: (2020)

Telemedicine as a strategic intervention for cognitive rehabilitation in MS patients during COVID-19
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

Beta-thalassemia intermedia with ischemic transients misdiagnosed as multiple sclerosis: A case report
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

The first presentation of COVID-19 two hours after vaccination in a patient with multiple sclerosis: Can COVID vaccine provoke cytokine storm in a patient with asymptomatic COVID-19?
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

Use of Social Media Tools during COVID-19 Pandemic Among MS Fellowships and Patients
por: Mokhberdezfuli, Mahdieh, et al.
Publicado: (2023)

Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients
por: Haji Akhoundi, Fahimeh, et al.
Publicado: (2020)

Suicidality risk after using cannabis and cannabinoids: An umbrella review
por: Shamabadi, Ahmad, et al.
Publicado: (2023)

Efficacy of Red Blood Cell Exchange as Adjunctive Treatment for Hypoxemia and Survival Rate of Patients With Severe Coronavirus-2 Disease: An Open-Labeled Phase 2 Randomized Clinical Trial
por: Aminianfar, Mohammad, et al.
Publicado: (2022)

Disability and Therapeutic Response in Paediatric Neuromyelitis Optica Spectrum Disorder: A Case Series from Iran
por: BAGHBANIAN, Seyed Mohammad, et al.
Publicado: (2019)

Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-β-1b: a case report
por: Sahraian, Mohammad Ali, et al.
Publicado: (2013)

Thrombotic microangiopathy associated with interferon-beta treatment in patients with multiple sclerosis
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2018)

Anti-N-methyl-D-aspartate receptor optic neuritis in a patient without history of encephalopathy
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2019)

Recurrent isolated optic neuritis: A study on 22 patients
por: Arzani, Mahsa, et al.
Publicado: (2017)

The Possible Direct Correlation between Cognitive Impairment and Fear of Catching COVID-19 among Patients with Multiple Sclerosis
por: Saeedi, Roghayyeh, et al.
Publicado: (2021)

Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV
por: Ali Sahraian, Mohammad, et al.
Publicado: (2021)

The study of COVID-19 infection following vaccination in patients with multiple sclerosis
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

Prevalence of COVID-19 infection in patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2021)

Attitudes toward vaccination in patients with multiple sclerosis: A report from Iran
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

The perspective of Iranian patients with multiple sclerosis on the third dose of COVID-19 vaccine
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

Validity and Reliability of the Persian Version of the PERception de la Scle’rose En Plaques et de ses Pousse’es Questionnaire Evaluating Multiple Sclerosis-related Quality of Life
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2016)

Ketamine and Other Glutamate Receptor Modulating Agents for Treatment-Resistant Depression: A Systematic Review of Randomized Controlled Trials
por: Shamabadi, Ahmad, et al.
Publicado: (2022)

Efficacy and safety of rituximab in patients with refractory neuromyelitis optica spectrum disorders: A prospective observation in Iranian cases
por: Seyed Ahadi, Maral, et al.
Publicado: (2020)

Acute attack in a patient with multiple sclerosis 2 days after COVID vaccination: a case report
por: Seyed Ahadi, Maral, et al.
Publicado: (2021)

Psychometric properties of the Persian version of emotions and attitudes towards MRI” (MRI-EMA)
por: Naser Moghadasi, Abdorreza, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s5suqermf585fac88thhsinr9p